Certain identified information has been omitted from this exhibit because it is not material and of the type that the registrant treats as private or confidential. [***] indicates that information has been omitted. ASSIGNMENT AND LICENSE AGREEMENT...Assignment and License Agreement • October 19th, 2021 • Environmental Impact Acquisition Corp • Biological products, (no disgnostic substances) • Delaware
This Agreement (“Agreement”) is made and entered into to be effective as of the Effective Date by and between Bayer CropScience LLP, having its principal business offices at 800 North Lindbergh Boulevard, St. Louis, Missouri 63167, and GreenLight Biosciences, Inc. having its principal business offices at 200 Boston Ave. Suite 1000, Medford, MA 02155 (“GreenLight”). Bayer CropScience LLP and GreenLight Biosciences, Inc. may be referred to herein individually as a “Party”, or collectively as the “Parties”.
Certain identified information has been omitted from this exhibit because it is not material and of the type that the registrant treats as private or confidential. [***] indicates that information has been omitted. NON-EXCLUSIVE LICENSE AGREEMENT...License Agreement • October 19th, 2021 • Environmental Impact Acquisition Corp • Biological products, (no disgnostic substances) • New York
This Non-Exclusive License Agreement (“License Agreement”), dated as of [ ] (the “License Agreement Effective Date”), is made by and between Acuitas Therapeutics, Inc., a British Columbia corporation (“Acuitas”), and GreenLight Biosciences Inc., a Delaware corporation (“GreenLight”). Each of Acuitas and GreenLight may be referred to herein as a “Party” or together as the “Parties.”
AMENDMENT INFORMATION Agreement to be Amended: Grant agreement between the Bill & Melinda Gates Foundation and Greenlight Biosciences, effective July 20, 2020, and bearing Investment [***] Amendment Purpose: No Cost Extension Amendment Date: Date of...Environmental Impact Acquisition Corp • October 19th, 2021 • Biological products, (no disgnostic substances)
THIS AMENDMENT amends, and is made part of, the above-referenced Agreement and is effective as of the date of this email. Capitalized terms not defined in this Amendment will have the meaning provided in the Agreement. Except as modified by this Amendment, all other terms and conditions of the Agreement remain in full force and effect. In the event of a conflict between the Agreement and this Amendment, the terms of this Amendment will prevail.
LOAN AND SECURITY AGREEMENTLoan and Security Agreement • October 19th, 2021 • Environmental Impact Acquisition Corp • Biological products, (no disgnostic substances)
Under the terms and conditions of the Loan and Security Agreement between Borrower and Bank (as amended, modified, supplemented, and/or restated from time to time, the “Agreement”), Borrower is in complete compliance for the period ending _______________ with all required covenants except as noted below. Attached are the required documents evidencing such compliance, setting forth calculations prepared in accordance with GAAP consistently applied from one period to the next except as explained in an accompanying letter or footnotes. Capitalized terms used but not otherwise defined herein shall have the meanings given them in the Agreement.
Development and Option Agreement by and between ACUITAS THERAPEUTICS, INC. and GREENLIGHT BIOSCIENCES INC. dated August 24, 2020Development and Option Agreement • October 19th, 2021 • Environmental Impact Acquisition Corp • Biological products, (no disgnostic substances) • New York
This Development and Option Agreement (this “Agreement”), dated as of August 24, 2020 (the “Effective Date”), is made by and between GreenLight Biosciences Inc., a Delaware corporation, (“GreenLight”) and Acuitas Therapeutics Inc., a British Columbia corporation (“Acuitas”). Each of GreenLight and Acuitas may be referred to herein as a “Party” or together as the “Parties.”
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • October 19th, 2021 • Environmental Impact Acquisition Corp • Biological products, (no disgnostic substances) • Massachusetts
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) made as of May 25th, 2015, by and between GreenLight Biosciences, Inc., a Delaware corporation (the “Company”), and Andrey Zarur, an individual (the “Employee”),
